Nodal Anaplastic Large-Cell Lymphoma ALK-1-with CD30+Cutaneous Lymphoproliferation Treated with Mistletoe: Spontaneous Remission or Treatment Response?

被引:8
|
作者
Kameda, G. [1 ]
Kempf, W. [2 ]
Oschlies, I. [3 ,4 ]
Michael, K. [1 ]
Seifert, G. [5 ]
Laengler, A. [1 ,6 ]
机构
[1] Gemeinschaftskrankenhaus, Abt Kinder & Jugendmed, Dept Integrat Pediat & Adolescent Med, D-58313 Herdecke, Germany
[2] Univ Zurich, Dept Dermatol, CH-8006 Zurich, Switzerland
[3] Univ Kiel, Dept Pathol, Hematopathol Sect, D-2300 Kiel, Germany
[4] Univ Kiel, Lymph Node Registry, D-2300 Kiel, Germany
[5] Univ Berlin Charite, Dept Pediat Oncol & Hematol, Berlin, Germany
[6] Ctr Integrat Med, Fac Hlth, Sch Med, Witten, Germany
来源
KLINISCHE PADIATRIE | 2011年 / 223卷 / 06期
关键词
lymphomatoid papulosis; primary cutaneous CD30+T-cell lymphoproliferation; mistletoe; complementary and alternativ medicine; PAPULOSIS;
D O I
10.1055/s-0031-1285914
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A 12-year old girl presented with general weakness and weight loss, a localised cervical lymph node enlargement and cutaneous lesions compatible with lymphomatoid papulosis (LyP). Biopsies from lymph node and skin revealed a histological diagnosis of nodal large cell ALK-1- anaplastic lymphoma (ALCL) with a synchronous CD30+ cutaneous lymphoproliferation consistent with lymphomatoid papulosis (LyP). The girl was treated with mistletoe (MT) as monotherapy. Within 1 week after initiation of MT-treatment the skin lesions and lymph node enlargement improved. Under continuing MT-therapy 30 months after diagnosis the patient is still in complete remission. It is not possible to know whether this was a rare case of spontaneous remission of the nodal and skin-manifestations of this CD30+ T-cell lymphoproliferation or whether the observed effect was a specific therapeutic response to MT-treatment.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 50 条
  • [1] Anaplastic large-cell lymphoma CD30(+) ALK(+)
    Kollarikova, L.
    Heizerova, M.
    Simaljakova, M.
    HAUTARZT, 2016, 67 (04): : 304 - 306
  • [2] Pyogenic variant of primary cutaneous CD30+anaplastic large-cell lymphoma: Spontaneous remission in a young adult
    Hees, Henrik
    Geissler, Eva M.
    Wolter, Manfred
    Lamos, Cristina
    Loeser, Christoph R.
    Dippel, Edgar
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (09): : 952 - 955
  • [3] Spontaneous complete remission in a CD30 positive, ALK1 negative, primary cutaneous anaplastic large cell lymphoma
    Kleemann, J.
    Kleimann, P.
    Hempel, K.
    Hrgovic, I.
    Valesky, E.
    Kaufmann, R.
    Meissner, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 160 - 160
  • [5] Treatment of primary cutaneous CD30+anaplastic large-cell lymphoma with radiation therapy
    Yu, James B.
    McNiff, Jennifer M.
    Lund, Molly W.
    Wilson, Lynn D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (05): : 1542 - 1545
  • [6] Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL)
    Mencia-Gutierrez, Enrique
    Gutierrez-Diaz, Esperanza
    Salamanca, Javier
    Martinez-Gonzalez, Miguel A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (06) : 766 - 769
  • [7] Primary cutaneous, large-cell anaplastic, CD30 positive Lymphoma
    Meyer, Y.
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 919 - 919
  • [8] Leukemic phase of primary cutaneous anaplastic large-cell lymphoma (ALK-negative), with downregulation of CD30
    Emily Glynn
    Andrei R. Shustov
    Claire Murphy
    Lori Soma
    Journal of Hematopathology, 2018, 11 : 45 - 49
  • [9] Leukemic phase of primary cutaneous anaplastic large-cell lymphoma (ALK-negative), with downregulation of CD30
    Glynn, Emily
    Shustov, Andrei R.
    Murphy, Claire
    Soma, Lori
    JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (02) : 45 - 49
  • [10] Cutaneous Manifestation of nodal anaplastic large cell ALK-CD30+T-Cell-Non-Hodgkin's Lymphoma
    Brinkmann, H.
    Inhoff, O.
    Dippel, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 228 - 228